Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Biomed Pharmacother ; 150: 112961, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35453006

ABSTRACT

Shikonin is an ointment produced from Lithospermun erythrorhizon which has been used in traditional medicine both in Europe and Asia for wound healing and is associated with anti-inflammatory properties. The goal of this work is to assess the analgesic properties of Shikonin in the CFA-induced inflammation model of pain. Rats were subjected to inflammation of the hind paw by CFA injection with a preventive injection of Shikonin and compared to either a control group or to a CFA-inflamed group with the vehicle drug solution. Inflammation of the hind paw by CFA was assessed by measurement of the dorsal to plantar diameter. Mechanical thresholds were established by means of the Von Frey filaments which are calibrated filaments that exert a defined force. Finally, the spinal cord of the studied animals was extracted to analyse the microglia population through immunohistochemistry using the specific marker Iba-1. Our results show that Shikonin reduces the paw oedema caused by CFA inflammation. Subsequently, there is a concomitant restoration of the mechanical thresholds reduced by CFA hind paw injection. Additionally, spinal microglia is activated after CFA-induced inflammation. Our results show that microglia is inhibited by Shikonin and has concomitant restoration of the mechanical thresholds. Our findings demonstrate for the first time that Shikonin inhibits microglia morphological changes and thereby ameliorates pain-like behaviour elicited by mechanical stimulation.


Subject(s)
Hyperalgesia , Microglia , Animals , Disease Models, Animal , Hyperalgesia/chemically induced , Inflammation/complications , Inflammation/drug therapy , Naphthoquinones , Pain/complications , Pain/drug therapy , Rats , Spinal Cord
2.
Stem Cell Reports ; 15(5): 1080-1094, 2020 11 10.
Article in English | MEDLINE | ID: mdl-33065045

ABSTRACT

Little is known about the intrinsic specification of postnatal cerebellar neural stem cells (NSCs) and to what extent they depend on information from their local niche. Here, we have used an adapted cell preparation of isolated postnatal NSCs and live imaging to demonstrate that cerebellar progenitors maintain their neurogenic nature by displaying hallmarks of NSCs. Furthermore, by using this preparation, all the cell types produced postnatally in the cerebellum, in similar relative proportions to those observed in vivo, can be monitored. The fact that neurogenesis occurs in such organized manner in the absence of signals from the local environment, suggests that cerebellar lineage progression is to an important extent governed by cell-intrinsic or pre-programmed events. Finally, we took advantage of the absence of the niche to assay the influence of the vesicular nucleotide transporter inhibition, which dramatically reduced the number of NSCs in vitro by promoting their progression toward neurogenesis.


Subject(s)
Cerebellum/metabolism , Neural Stem Cells/cytology , Neurogenesis , Nucleotide Transport Proteins/physiology , Time-Lapse Imaging , Animals , Cell Cycle , Cell Differentiation , Cell Division , Cell Lineage , Cell Proliferation , Cells, Cultured , Mice , Mice, Inbred C57BL , Microscopy , Single-Cell Analysis
3.
J Med Chem ; 59(24): 11027-11038, 2016 12 22.
Article in English | MEDLINE | ID: mdl-27958743

ABSTRACT

Opioids are widely used to treat millions suffering from pain, but their analgesic utility is limited due to associated side effects. Herein we report the development and evaluation of a chemical probe exhibiting analgesia and reduced opioid-induced side effects. This compound, kurkinorin (5), is a potent and selective µ-opioid receptor (MOR) agonist (EC50 = 1.2 nM, >8000 µ/κ selectivity). 5 is a biased activator of MOR-induced G-protein signaling over ß-arrestin-2 recruitment. Metadynamics simulations of 5's binding to a MOR crystal structure suggest energetically preferred binding modes that differ from crystallographic ligands. In vivo studies with 5 demonstrate centrally mediated antinociception, significantly reduced rewarding effects, tolerance, and sedation. We propose that this novel MOR agonist may represent a valuable tool in distinguishing the pathways involved in MOR-induced analgesia from its side effects.


Subject(s)
Analgesics, Opioid/pharmacology , Diterpenes/pharmacology , Pain/drug therapy , Receptors, Opioid, mu/agonists , Salvia/chemistry , Analgesics, Opioid/chemical synthesis , Analgesics, Opioid/chemistry , Animals , CHO Cells , Cells, Cultured , Cricetulus , Diterpenes/chemical synthesis , Diterpenes/chemistry , Diterpenes, Clerodane , Dose-Response Relationship, Drug , Male , Molecular Structure , Pain Measurement , Rats , Rats, Sprague-Dawley , Structure-Activity Relationship
4.
J Cell Physiol ; 228(4): 860-70, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23018770

ABSTRACT

Transient Receptor Potential Vanilloid type 1 channel (TRPV1) is an important endogenous transducer of noxious heat and chemical stimuli and is required during development of inflammatory hypersensitivity. The transcription factor Runx1 is known to play a relevant role in sensory neuron differentiation as it controls the expression of several sensory nociceptive receptors, including TRPV1. Here, we show that Runx1 up-regulates TRPV1 transcription activity by interacting directly with the proximal TRPV1 gene promoter sequence. Importantly, C/EBPß a well-established heterodimer partner of Runx1 also binds to the TRPV1 promoter and cooperates with Runx1 to further stimulate TRPV1 transcription. Our results support a mechanism where Runx1-C/EBPß-containing transcription regulatory complexes are recruited to the TRPV1 gene promoter to modulate TRPV1 expression in dorsal root ganglia neurons.


Subject(s)
CCAAT-Enhancer-Binding Protein-beta/genetics , Core Binding Factor Alpha 2 Subunit/genetics , Pain/genetics , TRPV Cation Channels/genetics , Animals , CCAAT-Enhancer-Binding Protein-beta/metabolism , Core Binding Factor Alpha 2 Subunit/metabolism , Ganglia, Spinal/metabolism , Neurons/metabolism , PC12 Cells , Pain/metabolism , Promoter Regions, Genetic , Rats , TRPV Cation Channels/biosynthesis , TRPV Cation Channels/metabolism , Transcription, Genetic , Transcriptional Activation , Up-Regulation
5.
Neuropharmacology ; 54(5): 863-73, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18329053

ABSTRACT

Early cannabinoid consumption may predispose individuals to the misuse of addictive drugs later in life. However, there is a lack of experimental evidence as to whether cannabinoid exposure during adolescence might differently affect opiate reinforcing efficacy and the opioid system in adults of both sexes. Our aim was to examine whether periadolescent chronic exposure to the cannabinoid agonist CP-55,940 could exert sex-dependent effects on morphine reinforcing and the opioid system in adulthood. Morphine reinforcing was studied under a progressive ratio (PR) reinforcement schedule in adult male and female rats that previously acquired morphine self-administration under a fixed ratio 1 (FR1) schedule. Binding levels and functionality of mu-opioid receptors were also evaluated. Periadolescent cannabinoid exposure altered morphine self-administration and the opioid system in adult rats in a sex-dependent manner. CP-55,940-exposed males exhibited higher self-administration rates under a FR1, but not under a PR schedule. In females, CP-55,940 did not modify morphine self-administration under either schedule. Moreover, CP-55,940 also increased mu-opioid receptor levels in the subcallosal streak of pre-treated animals and decreased mu-opioid receptor functionality in the nucleus accumbens shell but again, only in males. Our data indicate that adult male rats exposed to the cannabinoid in adolescence self-administer more morphine than females, but only when the demands required by the schedule of reinforcement are low, which might be related to the decrease in mu-opioid receptor functionality in the NAcc-shell observed in these animals.


Subject(s)
Analgesics, Opioid/metabolism , Analgesics/administration & dosage , Conditioning, Operant/drug effects , Cyclohexanols/pharmacology , Morphine/administration & dosage , Sex Characteristics , Animals , Autoradiography/methods , Behavior, Animal/drug effects , Behavior, Animal/physiology , Brain/drug effects , Brain/metabolism , Enkephalin, Ala(2)-MePhe(4)-Gly(5)-/pharmacology , Female , Guanosine 5'-O-(3-Thiotriphosphate)/metabolism , Male , Protein Binding/drug effects , Rats , Rats, Wistar , Receptors, Opioid, mu/physiology , Reinforcement Schedule , Self Administration , Statistics, Nonparametric , Sulfur Isotopes/metabolism
6.
Psychopharmacology (Berl) ; 170(3): 301-308, 2003 Nov.
Article in English | MEDLINE | ID: mdl-12955302

ABSTRACT

RATIONALE: Despite the increasing use of cannabis among adolescents, there is scarce information about the long-term effects of cannabinoid receptor agonists in appropriate animal models. OBJECTIVES: We aimed to investigate the behavioural features of adult male and female Wistar rats that had been exposed to a chronic treatment with the cannabinoid receptor agonist CP 55,940 (CP) during the juvenile period. METHODS: CP (0.4 mg/kg i.p.) or its corresponding vehicle was administered once daily, from day 35 to day 45. In adulthood, the animals were tested in the holeboard, the open field and the elevated plus-maze, under different stress (illumination) conditions. After a resting period, the serum corticosterone levels (radioimmunoassay) of the animals were measured. The effects of CP on food intake and somatic growth were monitored throughout the experimental period. RESULTS: The CP treatment induced significant sex-dependent effects on holeboard activity, as well as a decrease in the level of emotionality/anxiety in the open field and in the plus-maze. The animals receiving CP also showed diminished food intake and body weights during the treatment period, but both parameters recovered normal values during the period after treatment. No significant effect of the CP treatment on corticosterone levels was found. CONCLUSIONS: The results demonstrate that chronic administration of CP during the peri-adolescent period resulted in marked behavioural effects in adulthood. The nature of these effects depended on the sex of the animals and on the specific behavioural test. The possible neurobiological substrates underlying the effects of CP are discussed.


Subject(s)
Analgesics/pharmacology , Corticosterone/blood , Cyclohexanols/pharmacology , Maze Learning/drug effects , Motor Activity/drug effects , Analysis of Variance , Animals , Body Weight/drug effects , Eating/drug effects , Female , Growth , Male , Rats , Rats, Wistar , Sex Factors , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...